A Prospective Study of Circulating Chemokines and Angiogenesis Markers and Risk of Multiple Myeloma and Its Precursor.

Jonathan N HofmannOla LandgrenRebecca LandyTroy J KempLoredana SantoCharlene M McShaneJoseph J ShearerQing LanNathaniel RothmanLigia A PintoRuth M PfeifferAllan HildesheimHormuzd A KatkiMark P Purdue

Published in: JNCI cancer spectrum (2019)

Our prospective findings provide new insights into mechanisms involved in MM development and suggest that systemic angiogenesis markers could potentially improve risk stratification models for MGUS patients.

Keyphrases

end stage renal disease
endothelial cells
multiple myeloma
newly diagnosed
ejection fraction
vascular endothelial growth factor
chronic kidney disease
prognostic factors
peritoneal dialysis
wound healing
drug induced